China
PE-backed Chinese fintech player Lufax files for US listing
Lufax, a Chinese online lending and wealth management platform valued at $39.4 billion following its most recent private funding round, has filed for an IPO in the US.
Genor Biopharma raises $372m in Hong Kong IPO
China-based Genor Biopharma, which counts Hillhouse Capital, Temasek Holdings and Qiming Venture Partners among its investors, has raised HK$2.88 billion ($372 million) through a Hong Kong IPO.
CDH, Oriza back Canadian Solar carve-out
Canadian Solar, a NASDAQ-listed solar power company, has raised RMB1.78 billion ($260 million) to carve out certain China-based assets ahead of a local IPO.
China's Hinova Pharma raises $147m Series C
Hinova Pharma, a Chinese drug developer has raised RMB1 billion ($147 million) in Series C funding from Shenzhen Investment, Hong Kong-listed Tigermed, Huarong Rongde Asset Management, CCB Internationa, and a fund run by Sinopharm Group and CICC Capital....
GP profile: Redpoint China Ventures
Redpoint China Ventures spun out from its US parent in 2016, but the knowledge it retained – and the communication that remains – has been key to moving early on enterprise technology
Linear raises $200m for China VC fund
Chinese venture capital firm Linear Capital has closed its fourth US dollar-denominated fund at nearly $200 million, taking its overall assets under management to $400 million.
PE-owned Asia data center business trades up after $540m IPO
Bain Capital-controlled data center operator Chindata Group Holdings gained 20% on its NASDAQ trading debut following a $540 million IPO.
PE-backed JD Health files for Hong Kong IPO
JD Health, the healthcare unit of Chinese e-commerce giant JD.com, has filed for Hong Kong IPO. The company’s backers include Hillhouse Capital, CPE, CICC Capital, and Baring Private Equity Asia.
China's M31 Capital closes debut fund at $450m
Chinese Venture Capital firm M31 Capital has raised $450 million for its debut US dollar-denominated fund, beating a target of $400 million.
HarbourVest backs IDG renminbi fund restructuring
IDG Capital has completed a renminbi fund restructuring in which assets have been transferred from one local currency vehicle to another backed by offshore investors. It is the first secondary deal of its kind to use the Qualified Foreign Limited Partner...
Gaorong seeks $1b for China VC fund
Chinese venture capital firm Gaorong Capital is targeting $1 billion for its fifth US dollar-denominated fund – twice the amount raised in the previous vintage.
China healthcare SaaS player Taimei raises $176m
Taimei Technology, a Chinese cloud-based software provider that serves the healthcare sector has raised RMB1.2 billion ($176 million) in funding led by Tencent Holdings, GL Ventures and Yunfeng Capital.
Vision Fund leads $319m round for China's XtalPi
China and US-based artificial intelligence-enabled drug development platform XtalPi has raised $319 million in Series C funding led by SoftBank Vision Fund, the investment arm of insurer PICC Group, and Morningside Venture Capital.
Lever invests five China alternative meat start-ups
Hong Kong and US-based food tech investor Lever VC has confirmed five investments in alternative protein start-ups from its recently launched China fund.
Southeast Asia VC: Knowledge transfers
When venture capital firms move into Southeast Asia, they often use existing operations in China or India as a launching pad. Different lessons can be learned from these two markets
CITIC, SF Holdings raise $308m China logistics fund
CITIC Capital and SF Holdings – the parent company of SF Express, China’s second-largest courier company – have launched a RMB2.1 billion ($308 million) fund that will invest in logistics properties.
Trustbridge assumes control of WeWork China
Trustbridge Partners has committed $200 million to WeWork's China operation as part of a deal that sees the business become fully independent from its US-headquartered parent.
China's InventisBio secures $147m Series D
GL Ventures, the China venture capital arm of Hillhouse Capital, has led a $147 million Series D round for Shanghai-based biotech developer InventisBio.
GGV targets $2b for China, US tech investments
GGV Capital will return to market with its latest set of China and US-focused funds, seeking to raise an aggregate $2 billion, up from $1.88 billion in the prior vintage.
BA Capital raises $147m for renminbi fund, hits first close on dollar fund
BA Capital, a Shanghai-based venture capital firm also known as Black Ant Capital, has raised RMB1 billion ($147 million) for its second renminbi-denominated fund.
Ascendent invests $500m in Chinese supermarket retailer
Ascendent Capital Partners has made by far its largest investment to date, committing $500 million to Chinese supermarket retailer Wumart ahead of a planned Hong Kong IPO.
China robotics player Cyclone gets $40m Series B
Matrix Partners China has led a $40 million Series B round for local robotics start-up Cyclone. Other investors include DCM, Lenovo Capital, Source Code Capital, and Renzhi Capital.
China AI: A rude awakening
Two years ago, artificial intelligence start-ups were the bright young things of China’s technology sector. Now these companies are struggling to justify their lofty valuations
China mobile recycling platform Aihuishou raises $100m
JD.com and Guotai Junan Securities have co-led an extended Series E round of $100 million for Aihuishou, a China-based electronic products recycling platform.